FDA cosmetics requirements for foreign brands in 2026
Updated
FDA does not approve cosmetics before they go on sale, except for color additives. What it requires is that each product is correctly classified, safe and properly labeled, because a product that makes drug claims is regulated as a drug. For a foreign brand, the practical work is deciding whether every SKU is a cosmetic, a drug or both, then getting the label and ingredients right before anything ships.
This guide explains the FDA rules a product must meet to be sold in the U.S. The MoCRA duties that sit on top (registration, listing, adverse events) are summarized here and covered fully in MoCRA compliance for international brands. How goods clear the border is in how to import cosmetics into the USA.
How FDA regulates cosmetics
The U.S. system works after the fact. Cosmetics and their ingredients need no FDA premarket approval, "with the exception of color additives" (FDA, FDA Authority Over Cosmetics). There is no approval dossier to file and wait on. Instead, the brand is responsible for selling a product that is safe, honestly labeled and in the right legal category, and FDA can act against products on the market or at the border that are not.
For brands used to the EU, Korea's MFDS or Saudi Arabia's SFDA, this cuts both ways. Fewer filings come before launch, but nobody signs off that you got it right. The questions below are the ones you answer yourself.
Cosmetic, drug or both
Intended use decides the category (FDA, Is It a Cosmetic, a Drug, or Both?).
- A cosmetic is applied to the body for cleansing, beautifying, promoting attractiveness or altering appearance.
- A drug is intended to diagnose, cure, mitigate, treat or prevent disease, or to affect the structure or any function of the body.
- A product can be both, and then it must meet both sets of rules. FDA's examples include antidandruff shampoo, antiperspirant deodorants, and moisturizers or makeup with sun-protection claims. FDA lists antibacterial and acne cleansers as drugs, or both.
FDA establishes intended use from label claims, advertising, your website and online content, consumer perception, and ingredients with a well-known therapeutic use. Claims FDA says make a product a drug include restoring hair growth, reducing cellulite, treating varicose veins, increasing or decreasing melanin, and regenerating cells. For essential-oil products, "helps you sleep" or "relieves muscle pain" are drug claims too.
| Claim on the product | Likely category | What follows |
|---|---|---|
| "Hydrates and smooths the look of skin" | Cosmetic | Cosmetic labeling and MoCRA |
| "SPF 30 daily moisturizer" | Cosmetic and OTC drug | Sunscreen monograph, Drug Facts, drug registration and cGMP |
| "Controls dandruff" | Cosmetic and OTC drug | Drug rules on top of cosmetic rules |
| "Regrows hair" or "regenerates cells" | Drug | Cannot be sold as a cosmetic with that claim |
| "Reduces melanin to lighten skin" | Drug | FDA says no OTC skin lightener is legally marketed |
Two clarifications save foreign brands real trouble. "Cosmeceutical" has no legal meaning in the U.S. And true soap (mostly alkali salts of fatty acids, cleaning by those compounds, sold only as soap) is regulated by the Consumer Product Safety Commission, not FDA; a cleanser with moisturizing or deodorizing claims is a cosmetic. Claim boundaries for skincare are covered in more depth in how to sell skincare products in the USA.
What needs approval: color additives
Color additives are the one area where premarket approval applies, and there is no "generally recognized as safe" shortcut (FDA, Color Additives History).
- Certified colors (synthetic organic dyes, lakes and pigments) must be batch-certified by FDA before they are sold.
- Exempt colors, mostly from plant or mineral sources such as cochineal extract, do not need batch certification but must still meet their listing regulations, including the uses they are permitted for.
A shade permitted in Seoul, Istanbul or Paris is not automatically permitted in the U.S., or for the same use, such as around the eyes. Color violations are a named FDA import alert, so check every colorant on every SKU against the U.S. listings before production.
One special case: coal-tar hair dyes are exempt from the adulteration provisions if the label carries the statutory caution, which calls for a patch test and warns against use on eyelashes or eyebrows.
Cosmetic labeling requirements
The core rules sit in the Fair Packaging and Labeling Act and 21 CFR Part 701.
| Element | Rule |
|---|---|
| Identity | On the principal display panel, as a principal feature, in bold type: a common, descriptive or fanciful name, or an illustration |
| Net quantity | In the bottom 30% of the principal display panel; weight for solids, semisolids and viscous products, fluid measure for liquids; in both inch/pound and metric units; minimum type size scales from 1/16 inch with panel size |
| Ingredients | Descending order of predominance; ingredients at 1% or less in any order after that, then color additives; names as set by 21 CFR 701.3, which in practice are mostly INCI names; "fragrance" and "flavor" may be used generically |
| Name and place of business | Manufacturer, packer or distributor, with "Distributed by" or a similar qualifier if the named company did not make it |
| Adverse event contact | A U.S. address, U.S. phone number or electronic contact, required by MoCRA since December 29, 2024 |
| Warnings | Conspicuous, bold, at least 1/16 inch; aerosols must say "Contents under pressure. Do not puncture or incinerate." |
| Language | Required information in English; if any other language appears, all required information in that language too |
Small packages with less than 12 square inches of label surface may print the ingredient list in 1/32-inch type, or place it in accompanying labeling under set display conditions. Country-of-origin marking ("Made in Türkiye") is a CBP rule, not an FDA rule, but it belongs on the same artwork. California adds its own layer, including Prop 65 warnings and banned ingredients, covered in California beauty market entry. If your labels need U.S. stickers applied after arrival, Abanro's labeling service handles application to your approved artwork.
Adulterated and misbranded
These two words are FDA's main enforcement tools. Broadly, a cosmetic is misbranded if its labeling is false or misleading in any particular or lacks required label information. It is adulterated if, for example, it contains a substance that may make it harmful in normal use, was made or held under insanitary conditions, or contains a color additive that is not permitted.
Mercury is a concrete example. Under 21 CFR 700.13, a cosmetic with mercury is adulterated unless it is below 1 ppm as an unavoidable trace, or up to 65 ppm as a preservative in eye-area products with no safe alternative. FDA says mercury as a skin-bleaching agent is not justified. Skin lighteners in general are a high-risk category: hydroquinone lighteners are unapproved new drugs, and FDA states there are no legally marketed OTC skin lightening products.
If your product is also an OTC drug
Sunscreens, SPF moisturizers and makeup, antidandruff shampoos, antiperspirants and acne treatments are OTC drugs in the U.S., and many are cosmetics as well. That brings a separate, heavier set of obligations:
- A monograph. Since the CARES Act (March 27, 2020), OTC monographs are amended by administrative order. For sunscreens, 2026 brought changes: bemotrizinol was added up to 6% (June 10, 2026), and PABA and trolamine salicylate were removed (September 11, 2026).
- Drug establishment registration and listing. Foreign establishments register before their drugs are imported and name a U.S. agent. Each drug carries a 10- or 11-digit NDC.
- A Drug Facts label with fixed headings: Active ingredient(s), Purpose, Use(s), Warnings, Directions, Other information, Inactive ingredients, Questions?
- Drug cGMP under 21 CFR 210 and 211, which the factory must meet.
- User fees. For fiscal year 2027, the OTC monograph drug facility fee is $47,891 and the contract manufacturing organization fee is $31,927 (Federal Register).
A lower-risk sequence is to launch cosmetic SKUs first and add SPF or other drug-cosmetics once the U.S. channel has proven itself.
MoCRA in brief
The Modernization of Cosmetics Regulation Act of 2022 added duties for cosmetics: facility registration (foreign facilities included, with a U.S. agent), product listing by the responsible person, serious adverse event reports within 15 business days, safety substantiation records and the label contact above. FDA charges no fee for registration or listing. Small businesses have a limited exemption, and some rules are still pending. All of it, with a checklist, is in MoCRA compliance for international beauty brands.
Myths to drop
- "FDA-approved," "FDA-registered product" or "FDA certified." FDA does not approve cosmetics, and registration is not approval. Labeling that implies otherwise risks being misleading.
- "You need an FDA certificate." There is no FDA approval certificate for cosmetics, and a "registration certificate" sold by a private agent is not FDA approval.
- "Small brands are exempt from FDA." The MoCRA exemption covers only registration, listing and future GMP rules, and does not apply to products that contact the eye's mucous membrane, are injected or taken internally, or alter appearance for more than 24 hours; labeling, safety and adverse event duties still apply.
- "Our home-market approval carries over." It can help with documentation, but the U.S. category, color and label rules must be checked on their own.
Pre-launch FDA checklist
- Classify every SKU as cosmetic, drug or both, using the label, website and ad claims together.
- Check every color additive against U.S. listings and permitted uses.
- Screen the formula for restricted substances such as mercury and for drug-type actives.
- Rebuild the label: identity, net quantity in both unit systems, INCI ingredient list, name and place of business, U.S. adverse event contact, warnings, English.
- Align marketing copy and social media with the cosmetic claims on the pack.
- Confirm MoCRA registration and listing, or a documented exemption.
- Keep safety substantiation records ready to show buyers and FDA.
Once that list is clean, the next question is commercial: will U.S. retailers and their customers buy it? Abanro's Beauty & Personal Care program answers that in Southern California over three months, for $3,950 with one SKU included and $1,900 per additional SKU, plus a 25% commission only on sales Abanro generates. It includes an initial regulatory readiness screening, so obvious label or claim gaps surface before your goods ship, and it spares you setting up a U.S. office, sales hire and warehouse lease first. Specialist regulatory work is quoted separately when needed.
This guide is general information, not legal or regulatory advice. FDA requirements depend on each product's formula, claims and intended use; confirm them with a qualified U.S. regulatory specialist before launch.